Across every industry, the adoption of artificial intelligence (AI) is increasing rapidly year after year. This growth and greater accessibility raise caution for its use in high-risk applications, such as in clinical research. Responsible oversight by clinical research professionals will be crucial, encompassing regulatory issues, organizational oversight, and professional standards.
“The clinical research community is poised for successful and responsible use of AI. Our unique blend of ethics, resiliency, flexibility, curiosity, and vision for a better future has made us successful not only in advancing clinical care, but also in advancing how we advance clinical care,” says David Vulcano, LCSW, MBA, CIP, RAC, FACRP, Vice President, Research Compliance & Integrity, HCA Healthcare, and author of this white paper.
PUBLICATION HIGHLIGHTS
CURATED RESOURCE CENTER
ACRP has launched an Artificial Intelligence Resource Center with commentaries on AI’s current impacts in the field and its potential future uses for improving efficiencies and effectiveness in clinical trials.